# A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to Adynovate

> **NCT04876365** · — · COMPLETED · sponsor: **Takeda** · enrollment: 153 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **OTHER:** Non-Interventional

## Key facts

- **NCT ID:** NCT04876365
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-30
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2023-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04876365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04876365, "A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to Adynovate". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04876365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*